Skip to main content

HCA Healthcare Value Stock - Dividend - Research Selection

Hca holdings

ISIN: US40412C1018 , WKN: A1JFMW

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

HCA Healthcare, Inc., through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services. It also operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, and adolescent and adult alcohol and drug abuse treatment and counseling. In addition, the company operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. As of February 12, 2018, it owned and operated 179 hospitals and 120 freestanding surgery centers, and various other healthcare facilities in 20 states and the United Kingdom. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


What Could HCA Healthcare (HCA) Union Protests Mean For Pay And Staffing?

2026-08-12
HCA Healthcare (NYSE:HCA) is facing nationwide union led protests as workers press for higher wages and improved staffing during ongoing contract negotiations. Union organizers say demonstrations span multiple HCA Healthcare facilities across the US and focus on pay, staffing ratios, and working conditions. The dispute centers on how HCA Healthcare allocates resources, including reported profits and share buybacks, relative to frontline labor costs and staffing levels. These protests...

HCA’s New Clinical and Ambulatory Structure: Strategic Tune-Up or Turning Point for HCA (HCA)?

2026-08-12
HCA Healthcare has appointed Michael Schlosser, M.D., as executive vice president and chief clinical officer and created a new Ambulatory Operations Group led by Charles Gressle, consolidating oversight of clinical services, digital transformation, and more than 2,700 outpatient facilities as part of a broad leadership realignment that began taking effect in 2026. An interesting angle for investors is that Schlosser will simultaneously run HCA’s Clinical Services Group and its digital...

HCA Healthcare’s former CFO on the role of partnerships in health

2026-08-11
Bill Rutherford, who served on the finance team of the Tennessee-based healthcare giant for decades, reflects on his career in health as he switches to board service in retirement.

ResMed Q4 Earnings Call Highlights

2026-08-09
ResMed (NYSE:RMD) reported fourth-quarter fiscal 2026 revenue growth of 9% on a reported basis, or 8% in constant currency, as demand for sleep devices and masks increased. Non-GAAP earnings per share rose 16% to $2.95, while the company expanded gross margin despite continued inflation in electroni

Top 50 High-Quality Dividend Growth Stocks For August 2026

2026-08-09
I track a curated universe of 50 high-quality dividend growth stocks to identify timely, attractive entry points for long-term total return. Check out the list here.

Which S&P500 stocks are moving before the opening bell on Friday?

2026-08-07
Before the opening bell on Friday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.

Outset Medical Q2 Earnings Call Highlights

2026-08-07
Outset Medical (NASDAQ:OM) reported second-quarter 2026 revenue of $31.6 million, up 1% from a year earlier and 14% sequentially, as the dialysis technology company cited commercial progress, improving margins and a new $40 million refresh agreement with HCA Healthcare. Chair and Chief Executive Of

Outset Medical Reports Second Quarter 2026 Results

2026-08-06
SAN JOSE, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today reported financial results for the second quarter ended June 30, 2026. Second Quarter and Recent Highlights Net revenue totaled $31.6 million, an increase of 1% compared to the prior-year period and an increase of 14% sequentially.Recurring revenue, consisting of

HCA Healthcare Announces Dr. Michael Schlosser as Executive Vice President and Chief Clinical Officer; Names Charles Gressle President of New Ambulatory Operations Group

2026-08-06
NASHVILLE, Tenn., August 06, 2026--HCA Healthcare, Inc. (NYSE:HCA) today announced that Michael Schlosser, M.D., MBA, senior vice president and chief transformation officer, has been appointed executive vice president and chief clinical officer, effective Sept. 1, 2026.

Jim Cramer Looked At This 'Not Great' Uranium Stock 'For Years'

2026-08-06
CNBC's Jim Cramer offers his takes on various companies, including CME Group, Alcoa, Rocket Lab, Fortinet, HCA Healthcare and Hubbell.